This installation of GI Genius is the first in Pennsylvania, according to a July 6 news release.
GI Genius is the only FDA-cleared, commercially available AI poly detection device, according to the release. A study published March 15 in Gastroenterology found that in conjunction with a colonoscopy, GI Genius can decrease polyp miss rates by nearly 50 percent.
The installation is the result of US Digestive Health’s collaboration with Medtronic, AmSurg and PE GI Solutions, US Digestive Health CEO Jerry Tillinger said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.